Authors:
van Muijlwijk-Koezen, JE
Timmerman, H
van der Sluis, RP
van de Stolpe, AC
Menge, WMPB
Beukers, MW
van der Graaf, PH
de Groote, M
IJzerman, AP
Citation: Je. Van Muijlwijk-koezen et al., Synthesis and use of FSCPX, an irreversible adenosine A(1) antagonist, as a 'receptor knock-down' tool, BIOORG MED, 11(6), 2001, pp. 815-818
Authors:
van Tilburg, EW
van der Klein, PAM
de Groote, M
Beukers, MW
Ijzerman, AP
Citation: Ew. Van Tilburg et al., Substituted 4-phenyl-2-(phenylcarboxamido)-1,3-thiazole derivatives as antagonists for the adenosine A(1) receptor, BIOORG MED, 11(15), 2001, pp. 2017-2019
Authors:
van Muijlwijk-Koezen, JE
Timmerman, H
Vollinga, RC
Kunzel, JFV
de Groote, M
Visser, S
Ijzerman, AP
Citation: Je. Van Muijlwijk-koezen et al., Thiazole and thiadiazole analogues as a novel class of adenosine receptor antagonists, J MED CHEM, 44(5), 2001, pp. 749-762
Authors:
van Tilburg, EW
van der Klein, PAM
von Frijtag, J
Kunzel, D
de Groote, M
Stannek, C
Lorenzen, A
IJzerman, AP
Citation: Ew. Van Tilburg et al., 5 '-O-alkyl ethers of N,2-substituted adenosine derivatives: Partial agonists for the adenosine A(1) and A(3) receptors, J MED CHEM, 44(18), 2001, pp. 2966-2975
Authors:
Kourounakis, A
Visser, C
de Groote, M
IJzerman, AP
Citation: A. Kourounakis et al., Differential effects of the allosteric enhancer (2-amino-4,5-dimethyl-trienyl)[3-(trifluoromethyl) phenyl]methanone (PD81,723) on agonist and antagonist binding and function at the human wild-type and a mutant (T277A) adenosine A(1) receptor, BIOCH PHARM, 61(2), 2001, pp. 137-144
Authors:
Kourounakis, AP
Visser, C
de Groote, M
IJzerman, AP
Citation: Ap. Kourounakis et al., Allosteric modulation of the rat adenosine A(1) receptor: Differential effects on agonist and antagonist binding, DRUG DEV R, 51(4), 2000, pp. 207-215
Authors:
de Zwart, M
de Groote, M
van der Klein, PAM
van Dun, S
Bronsing, R
Kunzel, JKVD
Ijzerman, AP
Citation: M. De Zwart et al., Phenyl-substituted N-6-phenyladenosines and N-6-phenyl-5 '-N-ethylcarboxamidoadenosines with high activity at human adenosine A(2B) receptors, DRUG DEV R, 49(2), 2000, pp. 85-93
Authors:
van Muijlwijk-Koezen, JE
Timmerman, H
van der Goot, H
Menge, WMPB
Kunzel, JFV
de Groote, M
IJzerman, AP
Citation: Je. Van Muijlwijk-koezen et al., Isoquinoline and quinazoline urea analogues as antagonists for the human adenosine A(3) receptor, J MED CHEM, 43(11), 2000, pp. 2227-2238
Authors:
de Zwart, M
Vollinga, RC
Beukers, MW
Sleegers, DF
Kunzel, JKVD
de Groote, M
Ijzerman, AP
Citation: M. De Zwart et al., Potent antagonists for the human adenosine A(2B) receptor. Derivatives of the triazolotriazine adenosine receptor antagonist ZM241385 with high affinity, DRUG DEV R, 48(3), 1999, pp. 95-103
Authors:
van Tilburg, EW
Kunzel, JVD
de Groote, M
Vollinga, RC
Lorenzen, A
IJzerman, AP
Citation: Ew. Van Tilburg et al., N-6,5 '-disubstituted adenosine derivatives as partial agonists for the human adenosine A(3) receptor, J MED CHEM, 42(8), 1999, pp. 1393-1400